Literature DB >> 33500534

Inflammation predicts new onset of depression in men, but not in women within a prospective, representative community cohort.

Mareike Ernst1, Elmar Brähler2, Daniëlle Otten2, Antonia M Werner2, Ana N Tibubos2, Iris Reiner2, Felix Wicke2, Jörg Wiltink2, Matthias Michal2, Markus Nagler3, Thomas Münzel4,5, Philipp S Wild3,6,5, Jochem König7, Norbert Pfeiffer8, Andreas Borta9, Karl J Lackner10,5, Manfred E Beutel2.   

Abstract

Depression has been associated with increased inflammation. However, only few large-scale, prospective studies have evaluated whether inflammation leads to new cases of depression and whether this association can be found in men and women. Longitudinal data of N = 10,357 adult participants with no evidence of depression at baseline (based on Patient Health Questionnaire (PHQ-9), lifetime diagnoses, and current antidepressant medication) were evaluated for depression 5 years later. Multivariate logistic regression models were used to predict the onset of depression based on C-reactive protein (CRP) and white blood cell count (WBC). We used interaction terms and separate analyses in men and women to investigate gender-dependent associations. Based on both markers, inflammation was predictive of new cases of depression 5 years later, even when adjusting for sociodemographic, physical health, health behavior variables, and baseline depression symptoms. As established by interaction terms and separate analyses, inflammatory markers were predictive of depression in men, but not in women. Additional predictors of new onset of depression were younger age, loneliness, smoking (only in men), cancer and less alcohol consumption (only in women). The study indicates gender differences in the etiology of depressive disorders within the community, with a greater role of physical factors in men.

Entities:  

Year:  2021        PMID: 33500534      PMCID: PMC7838404          DOI: 10.1038/s41598-021-81927-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  57 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Depressive symptoms predict incident chronic disease burden 10 years later: Findings from the English Longitudinal Study of Ageing (ELSA).

Authors:  Lydia Poole; Andrew Steptoe
Journal:  J Psychosom Res       Date:  2018-07-21       Impact factor: 3.006

3.  Association of depression with peripheral leukocyte counts in EPIC-Norfolk--role of sex and cigarette smoking.

Authors:  Paul Surtees; Nicholas Wainwright; Nicholas Day; Robert Luben; Carol Brayne; Kay-Tee Khaw
Journal:  J Psychosom Res       Date:  2003-04       Impact factor: 3.006

4.  The relation between healthy lifestyle changes and decrease in systemic inflammation in patients with stable cardiovascular disease.

Authors:  C C van 't Klooster; Y van der Graaf; P M Ridker; J Westerink; J Hjortnaes; I Sluijs; F W Asselbergs; M L Bots; L J Kappelle; F L J Visseren
Journal:  Atherosclerosis       Date:  2020-04-06       Impact factor: 5.162

5.  Depression and cancer mortality: a meta-analysis.

Authors:  M Pinquart; P R Duberstein
Journal:  Psychol Med       Date:  2010-01-20       Impact factor: 7.723

6.  Diagnosing ICD-10 depressive episodes: superior criterion validity of the Patient Health Questionnaire.

Authors:  Bernd Löwe; Kerstin Gräfe; Stephan Zipfel; Steffen Witte; Bernd Loerch; Wolfgang Herzog
Journal:  Psychother Psychosom       Date:  2004 Nov-Dec       Impact factor: 17.659

7.  Association between depression and elevated C-reactive protein.

Authors:  Marion Danner; Stanislav V Kasl; Jerome L Abramson; Viola Vaccarino
Journal:  Psychosom Med       Date:  2003 May-Jun       Impact factor: 4.312

8.  Differential associations of depressive symptom dimensions with cardio-vascular disease in the community: results from the Gutenberg health study.

Authors:  Matthias Michal; Jörg Wiltink; Yvonne Kirschner; Philipp S Wild; Thomas Münzel; Francisco M Ojeda; Tanja Zeller; Renate B Schnabel; Karl Lackner; Maria Blettner; Isabella Zwiener; Manfred E Beutel
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

Review 9.  Gender differences in sepsis: cardiovascular and immunological aspects.

Authors:  Martin K Angele; Sebastian Pratschke; William J Hubbard; Irshad H Chaudry
Journal:  Virulence       Date:  2013-11-05       Impact factor: 5.882

10.  Course of depressive symptoms in men and women: differential effects of social, psychological, behavioral and somatic predictors.

Authors:  Ana N Tibubos; Elmar Brähler; Mareike Ernst; Carlotta Baumgarten; Joerg Wiltink; Juliane Burghardt; Matthias Michal; Jasmin Ghaemi Kerahrodi; Andreas Schulz; Philipp S Wild; Thomas Münzel; Irene Schmidtmann; Karl J Lackner; Norbert Pfeiffer; Andreas Borta; Manfred E Beutel
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

View more
  2 in total

1.  Neuroinflammation as a pathophysiological factor in the development and maintenance of functional seizures: A hypothesis.

Authors:  Ayushe A Sharma; Jerzy P Szaflarski
Journal:  Epilepsy Behav Rep       Date:  2021-10-26

2.  The Antidepressant Duloxetine Inhibits Platelet Function and Protects against Thrombosis.

Authors:  Patricia A Lozano; Ahmed B Alarabi; Sarah E Garcia; Erica T Boakye; Hendreta T Kingbong; Elie Naddour; Daniel Villalobos-García; Precious Badejo; Medhat S El-Halawany; Fadi T Khasawneh; Fatima Z Alshbool
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.